Advanced heart failure management with ventricular assist therapy – Evaluating Australian costs of care and effectiveness from implant to transplant or end of life

通过心室辅助治疗进行先进的心力衰竭管理 — 评估澳大利亚从植入到移植或生命终结的护理成本和有效性

• 批准号: nhmrc : GNT1133337
• 负责人: Ms Roslyn Prichard
• 金额: $ 3.05万
• 依托单位: University of Technology Sydney
• 依托单位国家: 澳大利亚
• 项目类别: Postgraduate Scholarships
• 财政年份: 2017
• 资助国家: 澳大利亚
• 起止时间: 2017-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/advanced-heart-failure-end-life/1347894
• 关键词: Advanced; heart; failure; management; ventricular

Ventricular Assist Devices (VADs) are implantable heart pumps that are increasingly being used to slow down the progression of end stage heart failure. This project assesses the costs and effectiveness of VAD therapy and advanced heart failure medical management in an Australian health care setting. The aim is to provide Australian clinicians and health decision makers access to current and relevant, clinical, cost and effectiveness data for advanced heart failure and VAD therapy.

心室辅助装置 (VAD) 是植入式心脏泵，越来越多地用于减缓终末期心力衰竭的进展。该项目评估澳大利亚医疗机构中 VAD 治疗和高级心力衰竭医疗管理的成本和有效性。目的是为澳大利亚临床医生和健康决策者提供晚期心力衰竭和 VAD 治疗的最新相关临床、成本和有效性数据。